1. Yang, Hui, Wang, Xinzhi, Blanco-Gómez, Adrián, Perez-Losada, Jesus, Mao, Jian-Hua. 2024. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice. In EBioMedicine, 106, 105260. doi:10.1016/j.ebiom.2024.105260. https://pubmed.ncbi.nlm.nih.gov/39067134/
2. Senatore, Emanuela, Chiuso, Francesco, Rinaldi, Laura, Conte, Ivan, Feliciello, Antonio. 2021. The TBC1D31/praja2 complex controls primary ciliogenesis through PKA-directed OFD1 ubiquitylation. In The EMBO journal, 40, e106503. doi:10.15252/embj.2020106503. https://pubmed.ncbi.nlm.nih.gov/33934390/
3. Cao, Pengbo, Chen, Hongxia, Zhang, Ying, He, Fuchu, Zhou, Gangqiao. 2024. Genomic Amplification of TBC1D31 Promotes Hepatocellular Carcinoma Through Reducing the Rab22A-Mediated Endolysosomal Trafficking and Degradation of EGFR. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2405459. doi:10.1002/advs.202405459. https://pubmed.ncbi.nlm.nih.gov/39206796/
4. Saygılı, Seha, Koşukcu, Can, Baştuğ, Turgut, Çalışkan, Salim, Ozaltin, Fatih. 2023. A novel homozygous missense variant in TBC1D31 in a consanguineous family with congenital anomalies of the kidney and urinary tract (CAKUT). In Clinical genetics, 104, 679-685. doi:10.1111/cge.14406. https://pubmed.ncbi.nlm.nih.gov/37468454/
5. Wang, Xiaofang, Xiao, Bo, Zhong, Fuping, Wang, Qibo, Jiang, Jihao. 2024. ZSCAN16 expedites hepatocellular carcinoma progression via activating TBC1D31. In Cell division, 19, 31. doi:10.1186/s13008-024-00135-9. https://pubmed.ncbi.nlm.nih.gov/39511655/